Skip to main content
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.1436
-0.0050 (-3.36%)
At close: Nov 13, 2026, 4:00 PM
0.1498
+0.0062 (4.32%)
After-hours: Nov 13, 2026, 4:54 PM EST

AIM ImmunoTech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.090.090.170.20.140.14
Revenue Growth
-18.75%-48.23%-15.84%43.26%4.44%-17.18%
Gross Profit
0.04-0.040.140.160.14-0.72
Operating Income
-11.65-11.66-19.77-31.92-19.92-17.06
Net Income
-14.13-13.96-17.32-28.96-19.45-19.13
Earnings Per Share
-1.24-8.62-30.92-59.55-40.43-40.36
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.953.053.9813.0734.1948.27
Total Debt
1.674.92.940.720.840.15
Net Cash (Debt)
5.28-1.851.0412.3533.3548.12
Net Cash Growth
7332.39%--91.61%-62.97%-30.69%-7.63%
Net Cash Per Share
0.37-1.141.8525.4069.35101.54

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.23-10.96-14.89-21.27-16.11-13.97
Capital Expenditures
---0.02--0.09-0.04
Free Cash Flow
-12.23-10.96-14.91-21.27-16.19-14.01
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
38.46%-45.45%81.77%79.21%100.00%-
Operating Margin
-12800.00%-13254.54%-11630.59%-15800.00%-14129.79%-12636.30%
Pretax Margin
-15526.37%-15861.36%-10188.24%-14337.62%-13790.78%-14168.15%
Profit Margin
-15526.37%-15861.36%-10188.24%-14337.62%-13790.78%-14168.15%
FCF Margin
-13435.17%-12451.14%-8768.24%-10528.22%-11485.11%-10374.81%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
49.7136.6474.28106.36106.36326.08